Sertaç Hanedan Onan
Sertaç Hanedan Onan has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Meltem Erol
Department of Pediatrics, Bağcılar Training and Research Hospital, University of Health Sciences Türkiye, Istanbul, Türkiye
3 shared publications - Ülkem Koçoğlu Barlas
Istanbul Medeniyet University, Turkey
3 shared publications - Abdulrahman Özel
Pediatric Intensive Care Unit, Department of Pediatrics, Bağcılar Training and Research Hospital, University of Health Sciences Türkiye, Istanbul, Türkiye
2 shared publications A. Baykan
Department of Pediatric Cardiology, Erciyes University Medical Faculty, Kayseri, Turkey
1 shared publicationAli Baykan
1 shared publication- Amra Adrovic
Department of Pediatric Rheumatology, Istanbul University-Cerrahpasa
1 shared publication
Latest Publications
- 14 September 2021
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 6 (3) , 295-301
Evaluation of Clinical Features of Patients Diagnosed with MIS-C
- 14 September 2021
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 6 (3) , 295-301
Evaluation of Clinical Features of Patients Diagnosed with MIS-C
- 14 September 2021
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 6 (3) , 350-354
A COVID-19-Related Kawasaki Disease: Our First Multi-system Inflammatory Syndrome in Children Case
- 14 September 2021
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 6 (3) , 350-354
A COVID-19-Related Kawasaki Disease: Our First Multi-system Inflammatory Syndrome in Children Case
- 5 June 2021
- Published by Springer Nature in Clinical Rheumatology
- Vol. 40 (10) , 4167-4178
Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children
Objectives Multi-system inflammatory syndrome in children (MIS-C) is a less understood and a rare complication of coronavirus disease-2019 (COVID-19). Given the scarce data regarding this novel disease, we aimed to describe the clinical features and outcomes of our patients with MIS-C and to evaluate the associated factors for the pediatric intensive care unit (PICU) admission. Methods The MIS-C patients under 18 years old diagnosed and treated in three referral centers between July 2020 and March 2021 were included. Data of the patients were retrospectively obtained from their medical records. Results Overall, 76 subjects (24 females) with a mean age of 8.17 ± 4.42 years were enrolled. Twenty-seven (35.5%) patients were admitted to the PICUs. The two most common systemic involvement patterns were cardiac and gastrointestinal. There was only one lethal outcome in a patient with underlying acute lymphoblastic leukemia. Those with higher procalcitonin levels at admission were found to stay longer in the hospital (r = 0.254, p = 0.027). The risk of PICU admission increased with age (aOR: 1.277; 95% CI: 1.089–1.498; p = 0.003) and with decreased initial serum albumin levels (aOR: 0.105; 95% CI: 0.029–0.378; p = 0.001). Conclusion Although there is a wide clinical variability among the patients with MIS-C, we suggest that those with older age and lower initial serum albumin levels merit close monitoring due to their higher risk for PICU admission. Key Points • Although there is a wide variability regarding the management process among clinicians, MIS-C is a rare, severe, less understood complication of COVID-19 that may cause rapid clinical deterioration in the patients. • Clinicians should be aware of this condition in children with persistent fever and a family history of COVID-19. • Older age and low serum albumin levels are the independent predictors for the pediatric intensive care unit admission among MIS-C patients.
- 5 June 2021
- Published by Springer Nature in Clinical Rheumatology
- Vol. 40 (10) , 4167-4178
Clinical features and outcomes of 76 patients with COVID-19-related multi-system inflammatory syndrome in children
Objectives Multi-system inflammatory syndrome in children (MIS-C) is a less understood and a rare complication of coronavirus disease-2019 (COVID-19). Given the scarce data regarding this novel disease, we aimed to describe the clinical features and outcomes of our patients with MIS-C and to evaluate the associated factors for the pediatric intensive care unit (PICU) admission. Methods The MIS-C patients under 18 years old diagnosed and treated in three referral centers between July 2020 and March 2021 were included. Data of the patients were retrospectively obtained from their medical records. Results Overall, 76 subjects (24 females) with a mean age of 8.17 ± 4.42 years were enrolled. Twenty-seven (35.5%) patients were admitted to the PICUs. The two most common systemic involvement patterns were cardiac and gastrointestinal. There was only one lethal outcome in a patient with underlying acute lymphoblastic leukemia. Those with higher procalcitonin levels at admission were found to stay longer in the hospital (r = 0.254, p = 0.027). The risk of PICU admission increased with age (aOR: 1.277; 95% CI: 1.089–1.498; p = 0.003) and with decreased initial serum albumin levels (aOR: 0.105; 95% CI: 0.029–0.378; p = 0.001). Conclusion Although there is a wide clinical variability among the patients with MIS-C, we suggest that those with older age and lower initial serum albumin levels merit close monitoring due to their higher risk for PICU admission. Key Points • Although there is a wide variability regarding the management process among clinicians, MIS-C is a rare, severe, less understood complication of COVID-19 that may cause rapid clinical deterioration in the patients. • Clinicians should be aware of this condition in children with persistent fever and a family history of COVID-19. • Older age and low serum albumin levels are the independent predictors for the pediatric intensive care unit admission among MIS-C patients.
- Open Access
- 1 January 2017
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 18 (1) , 75-76
Evaluation of vitamin D levels in patients with acute rheumatic fever
- 1 January 2017
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 18 (1) , 75-76
Open AccessEvaluation of vitamin D levels in patients with acute rheumatic fever
- 20 November 2015
- Published by Springer Nature in Pediatric Cardiology
- Vol. 37 (3) , 472-481
Evaluation of Cardiovascular Changes in Children with BAVs
The objectives of this study were to investigate left ventricular (LV) function, aortic dilation, and atherosclerosis in children with mildly deteriorated isolated bicuspid aortic valve (BAV) function using echocardiographic studies and biochemical markers of atherosclerosis and to correlate results with normal children. Biochemical analyses indicating cardiovascular risk of atherosclerosis and vascular changes in the aorta in relation to BAV were performed in 41 children aged 5–15 years old with isolated BAV and in 25 children with tricuspid aortic valves. Evaluations of aortic valve structures and functions; examinations of the LV M-mode and ascending aorta Doppler; and measurements of the LV Tei index (MPI), propagation velocity, ascending aorta at four levels, and carotid intima–media thickness (CIMT) were performed. There were no statistically significant differences in CIMTs, plasma matrix metalloproteinase-9, tissue metalloproteinase inhibitor-1 levels, or other biochemical parameters indicating cardiovascular risk or atherosclerosis between study and control groups. Deterioration of LV function, which could not be seen with M-mode echocardiography, was evident by MPI. MPI values in the study versus control groups were 0.46 ± 0.080 versus 0.40 ± 0.086 (p < 0.05). Diameters of the aorta in the study and control groups were 19.7 ± 4.7 and 17.2 ± 2.8 mm (p < 0.05) at the sinotubular junction level and 20.6 (14.4–40.5) and 18.3 (12.4–24) mm at the ascending aorta level (p < 0.05). Increased aortic valve insufficiency was related to increased aortic diameter. No sign of atherosclerosis was detected in children with BAV. Deterioration of LV function was seen using MPI, and aortic dilation was related to the severity of aortic valve insufficiency.
- 20 November 2015
- Published by Springer Nature in Pediatric Cardiology
- Vol. 37 (3) , 472-481
Evaluation of Cardiovascular Changes in Children with BAVs
The objectives of this study were to investigate left ventricular (LV) function, aortic dilation, and atherosclerosis in children with mildly deteriorated isolated bicuspid aortic valve (BAV) function using echocardiographic studies and biochemical markers of atherosclerosis and to correlate results with normal children. Biochemical analyses indicating cardiovascular risk of atherosclerosis and vascular changes in the aorta in relation to BAV were performed in 41 children aged 5–15 years old with isolated BAV and in 25 children with tricuspid aortic valves. Evaluations of aortic valve structures and functions; examinations of the LV M-mode and ascending aorta Doppler; and measurements of the LV Tei index (MPI), propagation velocity, ascending aorta at four levels, and carotid intima–media thickness (CIMT) were performed. There were no statistically significant differences in CIMTs, plasma matrix metalloproteinase-9, tissue metalloproteinase inhibitor-1 levels, or other biochemical parameters indicating cardiovascular risk or atherosclerosis between study and control groups. Deterioration of LV function, which could not be seen with M-mode echocardiography, was evident by MPI. MPI values in the study versus control groups were 0.46 ± 0.080 versus 0.40 ± 0.086 (p < 0.05). Diameters of the aorta in the study and control groups were 19.7 ± 4.7 and 17.2 ± 2.8 mm (p < 0.05) at the sinotubular junction level and 20.6 (14.4–40.5) and 18.3 (12.4–24) mm at the ascending aorta level (p < 0.05). Increased aortic valve insufficiency was related to increased aortic diameter. No sign of atherosclerosis was detected in children with BAV. Deterioration of LV function was seen using MPI, and aortic dilation was related to the severity of aortic valve insufficiency.
- 1 September 2012
- Published by Kare Publishing in Erciyes Tıp Dergisi/Erciyes Medical Journal
- Vol. 34 (3) , 155-157
An Adolescent with Pulmonary Hypertension Secondary to Idiopathic Fibrosing Mediastinitis: Case Report
- 1 September 2012
- Published by Kare Publishing in Erciyes Tıp Dergisi/Erciyes Medical Journal
- Vol. 34 (3) , 155-157
An Adolescent with Pulmonary Hypertension Secondary to Idiopathic Fibrosing Mediastinitis: Case Report